Japan Medical Dynamic Marketing (FRA:JMD) Cyclically Adjusted Revenue per Share: €4.21 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:JMD Japan Medical Dynamic Marketing Inc FRA:JMD
77 GF Score
Price €5.00
GF Value €3.36
! 12 Warning Signs
View Full Analysis

What is Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share?

Japan Medical Dynamic Marketing FRA:JMD -0.99% 77 Cyclically Adjusted Revenue per Share is €4.21 as of Mar. 2026. GuruFocus rates FRA:JMD with a GF Score™ of 77/100 and a GF Value™ of €3.36. The stock has 12 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Japan Medical Dynamic Marketing's adjusted revenue per share for the three months ended in Mar. 2026 was €1.239. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €4.21 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Japan Medical Dynamic Marketing's average Cyclically Adjusted Revenue Growth Rate was 6.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 9.00% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Japan Medical Dynamic Marketing was 11.00% per year. The lowest was 6.60% per year. And the median was 9.00% per year.

As of today (2026-07-22), Japan Medical Dynamic Marketing's current stock price is €5.00. Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was €4.21. Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio of today is 1.19.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Japan Medical Dynamic Marketing was 5.40. The lowest was 0.61. And the median was 2.31.


Japan Medical Dynamic Marketing  (FRA:JMD) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.00/4.21
=1.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Japan Medical Dynamic Marketing was 5.40. The lowest was 0.61. And the median was 2.31.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Related Terms


Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Chart

Japan Medical Dynamic Marketing Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.92 4.13 3.97 4.55 4.21

Japan Medical Dynamic Marketing Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.55 4.40 4.32 4.12 4.21

FRA:JMD vs ABT, SYK, MDT: Cyclically Adjusted Revenue per Share Comparison

For the Medical Devices subindustry, Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Medical Dynamic Marketing Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Japan Medical Dynamic Marketing's Cyclically Adjusted PS Ratio falls into.


FRA:JMD
77GF Score
Japan Medical Dynamic Marketing Inc FRA:JMD
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Medical Dynamic Marketing Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Japan Medical Dynamic Marketing's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.239/112.7000*112.7000
=1.239

Current CPI (Mar. 2026) = 112.7000.

Japan Medical Dynamic Marketing Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.031 98.100 1.184
201609 1.047 98.000 1.204
201612 1.083 98.400 1.240
201703 1.169 98.100 1.343
201706 1.024 98.500 1.172
201709 0.931 98.800 1.062
201712 1.142 99.400 1.295
201803 1.206 99.200 1.370
201806 1.109 99.200 1.260
201809 1.097 99.900 1.238
201812 1.333 99.700 1.507
201903 1.414 99.700 1.598
201906 1.354 99.800 1.529
201909 1.413 100.100 1.591
201912 1.476 100.500 1.655
202003 1.458 100.300 1.638
202006 1.067 99.900 1.204
202009 1.324 99.900 1.494
202012 1.367 99.300 1.551
202103 1.297 99.900 1.463
202106 1.296 99.500 1.468
202109 1.264 100.100 1.423
202112 1.509 100.100 1.699
202203 1.513 101.100 1.687
202206 1.346 101.800 1.490
202209 1.326 103.100 1.449
202212 1.494 104.100 1.617
202303 1.510 104.400 1.630
202306 1.341 105.200 1.437
202309 1.336 106.200 1.418
202312 1.461 106.800 1.542
202403 1.442 107.200 1.516
202406 1.353 108.200 1.409
202409 1.380 108.900 1.428
202412 1.566 110.700 1.594
202503 1.568 111.100 1.591
202506 1.348 111.700 1.360
202509 1.245 112.000 1.253
202512 1.313 113.000 1.310
202603 1.239 112.700 1.239

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €4.21 mean?
Japan Medical Dynamic Marketing (FRA:JMD) has a Cyclically Adjusted Revenue per Share of €4.21 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Japan Medical Dynamic Marketing and its competitors.
Is Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share too high?
Japan Medical Dynamic Marketing's current Cyclically Adjusted Revenue per Share is €4.21. Overall, Japan Medical Dynamic Marketing has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share compare to ABT and SYK?
Japan Medical Dynamic Marketing's Cyclically Adjusted Revenue per Share of €4.21 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Japan Medical Dynamic Marketing and its competitors. Japan Medical Dynamic Marketing's current Cyclically Adjusted Revenue per Share is €4.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Medical Dynamic Marketing stock overvalued right now?
Japan Medical Dynamic Marketing (FRA:JMD) has a current Cyclically Adjusted Revenue per Share of €4.21. The stock's GF Value™ is €3.36, compared to a current price of €5.00 — trading 48.8% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €4.21. Japan Medical Dynamic Marketing's overall GF Score™ is 77/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Japan Medical Dynamic Marketing (FRA:JMD), the current Cyclically Adjusted Revenue per Share is €4.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Medical Dynamic Marketing (FRA:JMD) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Medical Dynamic Marketing stock appears to be overvalued. The current stock price of €5.00 is trading 48.8% above its estimated GF Value™ of €3.36.

Key valuation signals for FRA:JMD:

  • Cyclically Adjusted Revenue per Share: €4.21
  • GF Value™: €3.36 vs. price of €5.00 (48.8% above fair value)
  • GF Score™: 77/100 with 12 warning signs

No single metric tells the full story. See the FRA:JMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Japan Medical Dynamic Marketing Business Description

Other Exchanges JMDMF:USA7600:Japan
Address 12-2, Ichigayadaimachi, Shinjuku-ku, Tokyo, JPN, 162-0066
Japan Medical Dynamic Marketing Inc is a Japan-based medical equipment manufacturer. The company is engaged in the development and sale of advanced medical devices. Products offered by the company include trauma devices, joint prostheses, spinal fixation devices, and artificial bone fillers. It caters its products to medical professionals and major hospitals throughout Japan. The company is also engaged in the import and sale of medical devices.
77GF Score

Get the complete analysis for FRA:JMD

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.00
Price
€3.36
GF Value